NCT07092137View on ClinicalTrials.gov

Nano-crystalline Megestrol Acetate for Anorexia-Cachexia Syndrome in Advanced Lung Cancer

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

October 10, 2025

Primary Completion Date

October 10, 2026

Study Completion Date

October 10, 2027

Conditions
Lung CancerCachexia-Anorexia Syndrome
Interventions
DRUG

Nano-crystalline Megestrol Acetate Oral Suspension

Nano-crystalline Megestrol Acetate+PD-(L)1 inhibitor (Q3W, until PD) + chemotherapy (based on guidelines)

OTHER

Nano-crystalline Megestrol Acetate Oral Suspension placebo

Nano-crystalline Megestrol Acetate placebo+PD-(L)1 inhibitor (Q3W, until PD) + chemotherapy (based on guidelines)

All Listed Sponsors
lead

Guangzhou Institute of Respiratory Disease

OTHER